Aspire Biopharma Holdings, Inc. (ASBP)

Aspire Biopharma Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	19	89	98	370
Market Cap Growth	188.15%	-8.80%	-73.55%	-
Enterprise Value	25	90	-	-
Last Close Price	0.40	11.50	10.89	10.30
PB Ratio	-	-57.98	-200.70	-2874.11
P/OCF Ratio	-	-	8792.61	-
Debt / Equity Ratio	-0.97	-0.82	-0.74	-0.22
Quick Ratio	0.15	0.00	0.02	0
Current Ratio	0.22	0.09	0.09	0.15
Return on Assets (ROA)	-	-779.55%	-652.34%	-
Earnings Yield	-87.23%	-1.47%	-0.37%	-0.16%
Buyback Yield / Dilution	-77.18%	0.68%	-	-

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q